Bio-Path Holdings (BPTH) Stock Highlights

2.06 | +6.74%

2024-06-03 05:10:21

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The companys lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003.

Statistics

Range Today

1.85 2.23

Volume Today 123.1K

Range 1 Year

0.32 12

Volume 1 Year 286.36M

Range 3 Year

0.32 12

Volume 3 Year 393.01M

Range 10 Year

0.32 724

Volume 10 Year 931.41M

Highlights

Market Capitalization 3.41M (micro)

Floating Shares 1.65M

Current Price 2.06

Price To Earnings -0.08

Earnings Per Share -25.26

Payout Ratio 0%

Performance

Latest +6.74%

1 Month -25.63%

3 Months -65.67%

6 Months +267.86%

1 Year +21.89%

3 Years -63.92%

5 Years -84.63%

10 Years -99.6%

Benchmarks

Market Capitalization

367 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

243 / 368

Free Cashflow

83 / 352

Performance 5 years

275 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.